Key result
Alloxan-induced diabetes triggers a pro-atherogenic lipid profile reflected by elevated AIP and TyG indices.
Why the study?
Does alloxan-induced hyperglycemia alter hormonal profiles and advanced lipid indices (AIP, TyG) in male Wistar rats?
Does alloxan-induced hyperglycemia alter hormonal profiles and advanced lipid indices (AIP, TyG) in male Wistar rats?
In a rat model, alloxan-induced hyperglycemia creates a pro-atherogenic metabolic profile, supporting the use of AIP and TyG indices as markers of experimental cardiometabolic risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kaya-Kimpolo et al. (2025) studied Experimental hyperglycemia (n=12). Alloxan monohydrate vs. Normoglycemic controls was evaluated on Advanced biochemical, hormonal, and lipid changes (blood glucose, insulin, leptin, serum lipids, HOMA-IR, HOMA-β, AIP, TyG). Alloxan-induced hyperglycemia in Wistar rats induces a pro-atherogenic metabolic signature, with AIP and TyG indices serving as relevant integrated markers of experimental cardiometabolic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: